Traveler’s Diarrhea Treatment Market is a digestive tract disorder characterized by an intestinal infection that generally occurs when a person consume contaminated food and water. This infection generally spreads through intestinal pathogens contracted while traveling where here the climatic conditions and sanitary practices are different from their home. Symptoms include loose stools, abdominal cramps, nausea and vomiting.
Traveler's diarrhea treatment market is growing at a substantial CAGR of 7.4% in the forecast period of 2020-2027. The report contains data of the base year 2019 and historic year 2018. This rise in market value can be attributed to the increasing cases of traveler’s diarrhea; which is boosting the traveler’s diarrhea treatment market.
Get Sample Report at :
Competitive Analysis: Global Traveler’s Diarrhea Treatment Market
The key market players in the traveler's diarrhea treatment market are Bayer AG, Merck & Co., Inc, Johnson & Johnson Services, Inc, Novartis AG, Valneva SE, Shanghai United Cell Biotechnology Co.,Ltd, PaxVax, Inc, Immuron, Salix Pharmaceuticals, F. Hoffmann-La Roche Ltd, Basilea Pharmaceutica Ltd, Eli Lilly and Company, Delcath Systems Inc, BridgeBio Inc, Incyte Corporation, Agios, Inc among others.
Key Pointers Covered in the Global Traveler’s Diarrhea Treatment Market Trends and Forecast to 2026
- Global Traveler’s Diarrhea Treatment Market New Sales Volumes
- Global Traveler’s Diarrhea Treatment Market Replacement Sales Volumes
- Global Traveler’s Diarrhea Treatment Market Installed Base
- Global Traveler’s Diarrhea Treatment Market By Brands
- Global Traveler’s Diarrhea Treatment Market Size
- Global Traveler’s Diarrhea Treatment Market Procedure Volumes
- Global Traveler’s Diarrhea Treatment Market Product Price Analysis
- Global Traveler’s Diarrhea Treatment Market Healthcare Outcomes
- Global Traveler’s Diarrhea Treatment Market Cost of Care Analysis
- Global Traveler’s Diarrhea Treatment Market Regulatory Framework and Changes
- Global Traveler’s Diarrhea Treatment Market Prices and Reimbursement Analysis
- Global Traveler’s Diarrhea Treatment Market Shares in Different Regions
- Recent Developments for Global Traveler’s Diarrhea Treatment Market Competitors
- Global Traveler’s Diarrhea Treatment Market Upcoming Applications
- Global Traveler’s Diarrhea Treatment Market Innovators Study
Get Detailed TOC:
https://www.databridgemarketresearch.com/toc/?dbmr=global-travelers-diarrhea-treatment-market
Key Developments in the Market:
- In November 2018, COSMO PHARMACEUTICALS received the U.S FDA approval for Aemcolo (rifamycin), an antibacterial drug indicated to treat adult patients with travelers’ diarrhea which is caused by noninvasive strains of Escherichia coli (E. coli). The approval of Aemcolo can potentially change the treatment landscape and offers complete treatment for millions of people each year.
- In February 2019, Dr. Falk Pharma GmbH is developing SV-MMX (Rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers’ diarrhea. If trial gets successful, it will provide the potential treatment for patients suffering from travelers’ diarrhea across the globe
Scope of the Traveler’s Diarrhea Treatment Market
- Global Traveler's Diarrhea Treatment Market By Drugs Class (Anti-Motility Agents, Antibiotics and Others), Drugs (Lomotil, Imodium, Pepto-Bismol, Rifaximin and Others), Route of Administration (Oral and Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End-Users (Hospitals, Homecare, Specialty Clinics and Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) - Industry Trends and Forecast to 2027
- Traveler's diarrhea treatment market is growing at a substantial CAGR of 7.4% in the forecast period of 2020-2027. The report contains data of the base year 2019 and historic year 2018. This rise in market value can be attributed to the increasing cases of traveler’s diarrhea; which is boosting the traveler’s diarrhea treatment market.
- Traveler's diarrhea is a digestive tract disorder characterized by an intestinal infection that generally occurs when a person consume contaminated food and water. This infection generally spreads through intestinal pathogens contracted while traveling where here the climatic conditions and sanitary practices are different from their home. Symptoms include loose stools, abdominal cramps, nausea and vomiting.
Speak to Author :
Key insights in the report:
- Complete and distinct analysis of the market drivers and restraints
- Key Market players involved in this industry
- Detailed analysis of the Market Segmentation
- Competitive analysis of the key players involved
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Browse Related Report Here: